Domain swapping in G-protein coupled receptor dimers

被引:106
作者
Gouldson, PR
Snell, CR
Bywater, RP
Higgs, C
Reynolds, CA
机构
[1] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England
[2] Novartis Inst Med Sci, London WC1E 6BN, England
[3] Novo Nordisk AS, Biostruct Dept, DK-2760 Malov, Denmark
来源
PROTEIN ENGINEERING | 1998年 / 11卷 / 12期
关键词
adrenergic receptor agonist; correlated mutations; domain swapping; G-protein coupled receptors; dimers;
D O I
10.1093/protein/11.12.1181
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Computer simulations were performed on models of the beta(2)-adrenergic receptor dimer, including 5,6-domain swapped dimers which have been proposed as the active, high affinity form (here the dimer interface lies between helices 5 and 6). The calculations suggest that the domain swapped dimer is a high energy structure in both the apo dimer and in the presence of propranolol. In the presence of agonist the energy of the domain swapped dimer is significantly lowered. Analysis of the dimer structure suggests that the agonist-induced conformational change optimizes the helix-helix interactions at the 5-6 interface. An antagonist on the other hand has little effect on these interactions. These observations are consistent with the hypothesis that the agonist functions by shifting the equilibrium in favour of the domain swapped dimer, Indirect support for the domain swapping hypothesis was obtained from the correlated mutations amongst the external residues of the known beta(2)-adrenergic receptors. These occur mainly at the 5-6 interface at precisely the locations predicted by the simulations; site-directed mutagenesis data in support of a functional role for these lipid-facing correlated residues is presented. The article includes a review of the experimental evidence for G-protein coupled receptor dimerization, Many other aspects of G-protein coupled receptor activation are discussed in terms of this domain swapping hypothesis.
引用
收藏
页码:1181 / 1193
页数:13
相关论文
共 106 条
  • [41] INTERACTION OF SUBSTANCE-P WITH THE 2ND AND 7TH TRANSMEMBRANE DOMAINS OF THE NEUROKININ-1 RECEPTOR
    HUANG, RRC
    YU, H
    STRADER, CD
    FONG, TM
    [J]. BIOCHEMISTRY, 1994, 33 (10) : 3007 - 3013
  • [42] IDENTIFICATION OF RESIDUES INVOLVED IN LIGAND-BINDING TO THE NEUROKININ-2 RECEPTOR
    HUANG, RRC
    VICARIO, PP
    STRADER, CD
    FONG, TM
    [J]. BIOCHEMISTRY, 1995, 34 (31) : 10048 - 10055
  • [43] INTRAMOLECULAR CAVITIES IN GLOBULAR-PROTEINS
    HUBBARD, SJ
    GROSS, KH
    ARGOS, P
    [J]. PROTEIN ENGINEERING, 1994, 7 (05): : 613 - 626
  • [44] A MODEL OF NONEXCLUSIVE BINDING OF AGONIST AND ANTAGONIST ON G-PROTEIN COUPLED RECEPTORS
    JARV, J
    [J]. JOURNAL OF THEORETICAL BIOLOGY, 1995, 175 (04) : 577 - 582
  • [45] Constitutive activation of the beta(2) adrenergic receptor alters the orientation of its sixth membrane-spanning segment
    Javitch, JA
    Fu, DY
    Liapakis, G
    Chen, JY
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) : 18546 - 18549
  • [46] MOLECULAR-DYNAMICS SIMULATIONS IN BIOLOGY
    KARPLUS, M
    PETSKO, GA
    [J]. NATURE, 1990, 347 (6294) : 631 - 639
  • [47] CHIMERIC ALPHA-2-ADRENERGIC, BETA-2-ADRENERGIC RECEPTORS - DELINEATION OF DOMAINS INVOLVED IN EFFECTOR COUPLING AND LIGAND-BINDING SPECIFICITY
    KOBILKA, BK
    KOBILKA, TS
    DANIEL, K
    REGAN, JW
    CARON, MG
    LEFKOWITZ, RJ
    [J]. SCIENCE, 1988, 240 (4857) : 1310 - 1316
  • [48] Kristiansen K, 1996, PROTEINS, V26, P81, DOI 10.1002/(SICI)1097-0134(199609)26:1<81::AID-PROT8>3.3.CO
  • [49] 2-R
  • [50] KUIPERS W, 1994, P MOL GRAPHICS SOC